Skip to main content
OpenTrials
Completed

NCT Number: NCT02289430

to Investigate the Pharmacokinetic Interactions and Safety Between Rosuvastatin and Ezetimibe in Healthy Male Volunteers

The purpose of this study is to compare the drug interaction of pharmacokinetics of rosuvastatin and ezetimibe.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy

Age range

19 year–45 year

Sex eligibility

Male

Study type

Interventional

Phase

Phase 1

About this study

drug interaction : rosuvastatin, ezetimibe

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy male subjects age between 19 and 45 singed informed consent

Exclusion criteria

  • Hypotension or hypertension has a history of allergy reaction of this drug or other drugs

Treatment and study plan

Crestor+Ezetrol

Drug

rosuvastatin+ezetimibe

Other names: rosuvatatin+ezetimibe

Ezetrol

Drug

ezetimibe

Other names: ezetimibe

CRESTOR

Drug

rosuvastatin

Other names: rosuvastatin

Primary outcomes

  1. Area Under Curve

    Time frame: 0-24h

Sponsors and collaborators

Lead sponsor

NVP Healthcare

Industry

Registry information

Official study title

A Phase I Clinical Trial to Investigate the Pharmacokinetic Interactions and Safety Between Rosuvastatin and Ezetimibe in Healthy Male Volunteers

Acronym: NVP-1205

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Nov 13, 2014
Registry last updated
Mar 25, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.